Therapeutic Areas

Gastrointestinal Diseases

With gastrointestinal diseases on the rise, there is a tremendous need for a CRO partner with strong scientific knowledge and a proven track record of success. AcelaBio has supported many clinical trials and clinical research of gastrointestinal diseases, including inflammatory bowel disease (IBD), eosinophilic gastrointestinal diseases (EGID), nonalcoholic steatohepatitis (NASH), and celiac disease (CeD).

Why AcelaBio?

  • Highly experienced team of pathologists, scientists, and operational expert
  •  Over 15,000 whole slide images generated across 30+ clinical trial
  • Consultation services to incorporate histology in all stages of clinical development
  • Scientific guidance on biomarkers discovery, selection, and development 
  • Strategic partnerships with global leaders in GI

Our clients benefit from the global network of GI specialists that offer the depth of expertise needed to achieve improved clinical trial outcomes. 

Gastrointestinal Diseases Services

  • Accessioning
  • Processing
  • Embedding
  • Sectioning
  • Hematoxylin & Eosin
  • Special Stains
  • In Situ Hybridization
  • Antibody Optimization
  • Assay Development
  • Immunostaining
  • Whole Slide Imaging
  • Storage & Archiving
  • Pathology Review
  • Data Management
  • Sample Logistics
  • Consulting
  • Project Management
  • Clinical Trial Support
  • RNA Extraction*
  • Spatial Transcriptomics*
  • Bioinformatics*
  • Digital Image Analysis*
*For Research Use Only (not for use in diagnostic procedures)

Oncology

In the era of precision medicine, biomarker identification is essential for cancer therapeutics development and cancer research. Being an expert in the field of histopathology and immunohistochemistry (IHC), AcelaBio can support a range of studies, from discovery to late-phase clinical trials.

Why AcelaBio?

  • Innovative technologies for biomarker discovery and development 
  • A wide array of validated immunohistochemistry (IHC) assays
  • Highest standard of quality         

As a CAP/CLIA accredited laboratory, we’re proud to deliver the highest quality standard to advance drug development and oncology research.

Oncology Services

  • Accessioning
  • Processing
  • Embedding
  • Sectioning
  • Hematoxylin & Eosin
  • Special Stains
  • In Situ Hybridization
  • Antibody Optimization
  • Assay Development
  • Immunostaining
  • Whole Slide Imaging
  • Storage & Archiving
  • Pathology Review
  • Data Management
  • Sample Logistics
  • Consulting
  • Project Management
  • RNA Extraction*
  • Spatial Transcriptomics*
  • Bioinformatics*
  • Digital Image Analysis*
*For Research Use Only (not for use in diagnostic procedures)

Dermatology

Skin specimens can be among the most difficult to process successfully from a histopathological perspective. Inaccurate sample orientation or poor formalin-fixed paraffin-embedded (FFPE) samples can be challenging. With our deep expertise across multiple therapeutic areas, we can overcome such challenges and support our clients in achieving the best study outcomes.

Why AcelaBio?

  • State-of-the-art equipment for end-to-end processing “from sample to score”
  • A wide array of validated immunohistochemistry (IHC) assays
  • Highest standard of quality             

As a CAP/CLIA accredited laboratory, we’re proud to deliver the highest quality standard to advance drug development and dermatology research.

Dermatology Services

  • Accessioning
  • Processing
  • Embedding
  • Sectioning
  • Hematoxylin & Eosin
  • Special Stains
  • In Situ Hybridization
  • Antibody Optimization
  • Assay Development
  • Immunostaining
  • Whole Slide Imaging
  • Storage & Archiving
  • Pathology Review
  • Data Management
  • Sample Logistics
  • Consulting
  • Project Management
  • RNA Extraction*
  • Spatial Transcriptomics*
  • Bioinformatics*
  • Digital Image Analysis*
*For Research Use Only (not for use in diagnostic procedures)